CAMBRIDGE, Mass.--(BUSINESS WIRE)--CIC Health and Quest Diagnostics (NYSE:DGX) today announced a collaboration that will help more schools safely return to in-person learning by greatly increasing ...
Quest Diagnostics and Quest Diagnostics Foundation are launching a $100 million investment program to reduce disparities in communities hardest hit by the coronavirus pandemic. Officials said the ...
| Quest Diagnostics emphases the critical role of in vitro diagnostics (IVDs) in shaping modern healthcare and advancing ...
Quest Diagnostics (NYSE: DGX) runs medical tests on one in three American adults each year, and there are treasure chests full of medical insights buried in the mountains of genetic data some of those ...
The arrangement serves as a case study for how outreach agreements can help hospital systems expand patient access to ...
SECAUCUS, N.J., and SAN DIEGO, Feb. 13, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced the launch of MelaNodal ...
Based on technology from SkylineDx, the test aims to aid treatment decisions for patients with the deadliest form of skin cancer Patients classified as low-risk by MelaNodal Predict are shown to have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback